Vaccine and Infectious Disease Division

Infection-Related Malignancies

Nearly one-quarter of cancers worldwide are caused by infectious diseases. Pathogens, such as Human Herpesvirus 8 (HHV-8) and Epstein Barr Virus (EBV), have been identified as contributing factors in lymphoma, sarcoma, liver cancer, prostate cancer, bladder cancer and stomach cancer. Researchers hope to answer a number of key questions: How are cancer-causing infections transmitted and acquired? What factors govern the progression from chronic infection to cancer? Which therapies can be employed to prevent infection-related cancers? VIDD has recently fostered a pioneering collaboration with the Uganda Cancer Institute, the only cancer care facility in Uganda, to delineate and establish efficacious treatment options. 

Faculty

Associate Member, Clinical Research Division
Director, UCI/Hutchinson Center Cancer Alliance, Fred Hutchinson Cancer Research Center
Director, Scientific Program on AIDS-Associated Malignancies and Infections, Fred Hutchinson Cancer Research Center
Phone: (206) 667-4600
Fax: (206) 667-1965
Associate Director for Laboratory Operations, HIV Vaccine Trials Network (HVTN)
Affiliate Assistant Professor, Biostatistics, University of Washington
Graduate Faculty, Biostatistics, University of Washington
Phone: (206) 667-6353
Fax: (206) 667-4378
Director of Clinical Development, HIV Vaccine Trials Network (HVTN)
Clinical Trials Physician/Protocol Team Leader, HIV Vaccine Trials Network (HVTN)
Professor, Medicine, Laboratory Medicine, and Epidemiology, University of Washington
Graduate Faculty, Medicine, Laboratory Medicine, and Epidemiology, University of Washington
Phone: (206) 520-4340
Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.